FDA Warning Letter — Regenerative Biologics Inc.

Case 672154 — FEI 1000307669

The FDA took a Warning Letter action against Regenerative Biologics Inc. on Aug 16, 2024 (Alachua, FL). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Regenerative Biologics Inc.
Date
Aug 16, 2024
Fiscal Year
2024
Product Type
Biologics
Center
CBER
Location
Alachua, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.